Crinetics Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. 

CEO
R. Scott Struthers
CEOR. Scott Struthers
Employees
594
Employees594
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
594
Employees594

CRNX Key Statistics

Market cap
8.85B
Market cap8.85B
Price-Earnings ratio
-16.28
Price-Earnings ratio-16.28
Dividend yield
Dividend yield
Average volume
13.16M
Average volume13.16M
High today
$83.76
High today$83.76
Low today
$83.56
Low today$83.56
Open price
$83.59
Open price$83.59
Volume
7.11M
Volume7.11M
52 Week high
$83.76
52 Week high$83.76
52 Week low
$25.83
52 Week low$25.83

Stock Snapshot

As of today, Crinetics Pharmaceuticals(CRNX) shares are valued at $83.57. The company's market cap stands at 8.85B, with a P/E ratio of -16.28.

During the trading session on 2026-07-12, Crinetics Pharmaceuticals(CRNX) shares reached a daily high of $83.76 and a low of $83.56. At a current price of $83.57, the stock is +0.0% higher than the low and still -0.2% under the high.

Trading volume for Crinetics Pharmaceuticals(CRNX) stock has reached 7.11M, versus its average volume of 13.16M.

The stock's 52-week range extends from a low of $25.83 to a high of $83.76.

The stock's 52-week range extends from a low of $25.83 to a high of $83.76.

CRNX News

TipRanks 2d
Crinetics Pharmaceuticals Announces Merger Agreement With Vertex

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

The Motley Fool 2d
Why This Pharmaceutical Stock Jumped Close to 100% This Week

Shares of Crinetics Pharmaceuticals (CRNX 0.02%) jumped 98% this week, according to data from S&P Global Market Intelligence. The upstart drugmaker is being acq...

Why This Pharmaceutical Stock Jumped Close to 100% This Week
Benzinga 4d
Here's How Much $1000 Invested In Crinetics Pharmaceuticals 5 Years Ago Would Be Worth Today - Benzinga

...

Here's How Much $1000 Invested In Crinetics Pharmaceuticals 5 Years Ago Would Be Worth Today - Benzinga

Analyst ratings

86%

of 14 ratings
Buy
14.3%
Hold
85.7%
Sell
0%

More CRNX News

Nasdaq 4d
Strength Seen in CRINETICS PHARM: Can Its 98.7% Jump Turn into More Strength?

Crinetics Pharmaceuticals, Inc. CRNX shares rallied 98.7% in the last trading session to close at $83.53. This move can be attributable to notable volume with a...

Strength Seen in CRINETICS PHARM: Can Its 98.7% Jump Turn into More Strength?
Simply Wall St 5d
Crinetics Pharmaceuticals Agreed To A $10 Billion All Cash Sale To Vertex

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals (NasdaqGS:CRNX) in an all cash deal valued at about US$10b. The boards of both companies app...

Crinetics Pharmaceuticals Agreed To A $10 Billion All Cash Sale To Vertex
TipRanks 6d
Vertex to Acquire Crinetics in $10 Billion Merger

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Benzinga 6d
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why

Crinetics Pharmaceuticals stock is soaring. What’s the outlook for CRNX shares? Vertex To Acquire Crinetics Crinetics and Vertex have entered into a definitiv...

Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
TipRanks 6d
Vertex to acquire Crinetics for $85 per share in cash

Vertex Pharmaceuticals Incorporated (VRTX) and Crinetics Pharmaceuticals, Inc. (CRNX), a global pharmaceutical company focused on the discovery, development and...

People also own

Based on the portfolios of people who own CRNX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.